Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Lymphoma and PIK3CA[original query] |
|---|
| Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
| Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas. Pigment cell & melanoma research 2013 Sep 26 (5): 646-53. Niu Hai-Tao, Zhou Qi-Ming, Wang Fang, Shao Qiong, Guan Yuan-Xiang, Wen Xi-Zhi, Chen Li-Zhen, Feng Qi-Sheng, Li Wei, Zeng Yi-Xin, Zhang Xiao-S |
| Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients. OncoTargets and therapy 2014 7 513-24. Li Hang, Hu Haichuan, Wang Rui, Pan Yunjian, Wang Lei, Li Yuan, Zhang Yang, Ye Ting, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu |
| Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
| Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer 2015 Dec . Steuer Conor E, Behera Madhusmita, Berry Lynne, Kim Sungjin, Rossi Michael, Sica Gabriel, Owonikoko Taofeek K, Johnson Bruce E, Kris Mark G, Bunn Paul A, Khuri Fadlo R, Garon Edward B, Ramalingam Suresh |
| [Advances on driver oncogenes of non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 1 18 (1): 42-7. Zhao Jianguo, Xiong Jianpi |
| High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Aug . Wiesweg Marcel, Eberhardt Wilfried E E, Reis Henning, Ting Saskia, Savvidou Nikoleta, Skiba Charlotte, Herold Thomas, Christoph Daniel C, Meiler Johannes, Worm Karl, Kasper Stefan, Theegarten Dirk, Hense Jörg, Hager Thomas, Darwiche Kaid, Oezkan Filiz, Aigner Clemens, Welter Stefan, Kühl Hilmar, Stuschke Martin, Schmid Kurt W, Schuler Mart |
| Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses. International journal of molecular sciences 2016 17 (5): . Todorovic Balint Milena, Jelicic Jelena, Mihaljevic Biljana, Kostic Jelena, Stanic Bojana, Balint Bela, Pejanovic Nadja, Lucic Bojana, Tosic Natasa, Marjanovic Irena, Stojiljkovic Maja, Karan-Djurasevic Teodora, Perisic Ognjen, Rakocevic Goran, Popovic Milos, Raicevic Sava, Bila Jelena, Antic Darko, Andjelic Bosko, Pavlovic Son |
| Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
| Genetic alterations in lung adenocarcinoma with a micropapillary component. Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
| KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jan . Hwang David H, Sholl Lynette M, Rojas-Rudilla Vanesa, Hall Dimity L, Shivdasani Priyanka, Garcia Elizabeth P, MacConaill Laura E, Vivero Marina, Hornick Jason L, Kuo Frank C, Lindeman Neal I, Dong F |
| A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 May . Ke E-E, Zhou Qing, Zhang Qiu-Yi, Su Jian, Chen Zhi-Hong, Zhang Xu-Chao, Xu Chong-Rui, Yang Jin-Ji, Tu Hai-Yan, Yan Hong-Hong, Zhang Yi-Chen, Niu Fei-Yu, Wu Yi-Lo |
| Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients. Clinical lung cancer 2017 Apr . Martorell Paloma Martín, Huerta Marisol, Quilis Amparo Compañ, Abellán Rosario, Seda Enrique, Blesa Sebastián, Chaves Felipe J, Beltrán Diego Dualde, Keränen Susana Roselló, Franco José, Insa Amel |
| Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 06 12 (6): 963-973. Guibert Nicolas, Barlesi Fabrice, Descourt Renaud, Léna Hervé, Besse Benjamin, Beau-Faller Michèle, Mosser Jean, Pichon Eric, Merlio Jean-Philippe, Ouafik L'Houcine, Guichard François, Mastroianni Bénédicte, Moreau Lionel, Wdowik Annie, Sabourin Jean-Christophe, Lemoine Antoinette, Missy Pascale, Langlais Alexandra, Moro-Sibilot Denis, Mazières Juli |
| ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 Jan . Lin Jessica J, Ritterhouse Lauren L, Ali Siraj M, Bailey Mark, Schrock Alexa B, Gainor Justin F, Ferris Lorin A, Mino-Kenudson Mari, Miller Vincent A, Iafrate Anthony J, Lennerz Jochen K, Shaw Alice |
| Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
| ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas. Oncology letters 2018 Dec 16 (6): 7091-7096. Osella-Abate Simona, Mereu Elisabetta, Pellegrino Elisa, Bergaggio Elisa, Ribero Simone, Bertero Luca, Lisa Francesco, Fierro Maria Teresa, Giulio Papotti Mauro, Piva Rober |
| Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma. Cancer research and treatment 2021 7 54 (2): 597-612. Yoon Sang Eun, Kim Yeon Jeong, Shim Joon Ho, Park Donghyun, Cho Junhun, Ko Young Hyeh, Park Woong-Yang, Mun Yeung-Chul, Lee Kyoung Eun, Cho Duck, Kim Won Seog, Kim Seok J |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Development of a multiplex allele-specific qPCR approach for testing PIK3CA mutations in patients with colorectal cancer. Heliyon 2022 12 8 (11): e11804. Oscorbin Igor P, Beginyazova Oguljan P, Khlistun Inna V, Shamovskaya Darya V, Oskina Natalia A, Filipenko Maxim |
- Page last reviewed:Feb 1, 2024
- Content source: